Rick, Wilder, and All,
I don't think IMCL got whacked hard enough, and it's in the WatchList now. BTW, someone on the IMCL thread said there was a patent challenge coming from ABGX. I thought it was from DNA. Could there be two challenges coming?
Don't know why I waited to pull the trigger on AMGN. Scared by seasonality, I guess.
I think I will soon, and on IMCL, too. Which I liked two years ago until it got beyond $30, but didn't dare reenter for reasons better expressed by V1.
I actually looked at TXBI and was about to post some stuff when the PC froze and I lost it. Then Rick said he wasn't serious. But it would have been a good trading call.
Any studies on the therapeutic value of champagne? No wait, we'd best not get started, but . . .
Happy New Years, All!
Cheers, Tuck |
